FDA Expands Acetaminophen, NSAID Labeling Beyond Tentative Final Rule
This article was originally published in The Tan Sheet
Executive Summary
FDA's final rule for OTC products containing acetaminophen or nonsteroidal anti-inflammatory drugs requires warnings and revisions that go beyond changes the agency proposed in a 2006 tentative final rule